Literature DB >> 15857985

Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

Rahnuma Wahid1, Martin J Cannon, Marie Chow.   

Abstract

The presence of poliovirus (PV)-specific CD4(+) T cells in individuals vaccinated against polio has been shown, but CD8(+) T-cell responses have not been described. Here, we functionally characterize the CD4(+) T-cell response and show for the first time that dendritic cells and macrophages can stimulate PV-specific CD8(+) T-cell responses in vitro from vaccinees. Both CD4(+) T and CD8(+) T cells secrete gamma interferon in response to PV antigens and are cytotoxic via the perforin/granzyme B-mediated pathway. Furthermore, the T cells also recognize and kill Sabin 1 vaccine-infected targets. The macrophage-stimulated CD4(+) T and CD8(+) T cells most likely represent memory T cells that persist for long periods in vaccinated individuals. Thus, immunity to PV vaccination involves not only an effective neutralizing antibody titer but also long-term CD4(+) and CD8(+) cytotoxic T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857985      PMCID: PMC1091702          DOI: 10.1128/JVI.79.10.5988-5995.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Authors:  S B Deitz; D A Dodd; S Cooper; P Parham; K Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses.

Authors:  Jane Marttila; Heikki Hyöty; Pekka Vilja; Taina Härkönen; Annu Alho; Merja Roivainen; Timo Hyypiä; Jorma Ilonen
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

Review 4.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 5.  Lymphocyte-mediated cytotoxicity.

Authors:  John H Russell; Timothy J Ley
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  Dendritic cells and macrophages are productively infected by poliovirus.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons.

Authors:  G K Binder; D E Griffin
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

8.  Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.

Authors:  A Khanolkar; H Yagita; M J Cannon
Journal:  Virology       Date:  2001-08-15       Impact factor: 3.616

9.  Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation.

Authors:  L J Sigal; K L Rock
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

10.  Fc gamma receptors and cross-presentation in dendritic cells.

Authors:  Sebastian Amigorena
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  31 in total

Review 1.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Virology       Date:  2011-01-08       Impact factor: 3.616

2.  Fas/FasL and perforin-granzyme pathways mediated T cell cytotoxic responses in infectious bursal disease virus infected chickens.

Authors:  Abdul Rauf; Mahesh Khatri; Maria V Murgia; Yehia M Saif
Journal:  Results Immunol       Date:  2012-05-16

Review 3.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

4.  Polio, still lurking in the shadows.

Authors:  Anthony N van den Pol
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 5.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

6.  Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination.

Authors:  Efrain Guzman; Geraldine Taylor; Bryan Charleston; Shirley A Ellis
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

Review 7.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

8.  Using IFN-gamma as a biomarker for detecting exposure to viral pathogens.

Authors:  Lu Li; Alfred P Dufour
Journal:  Curr Microbiol       Date:  2007-10-10       Impact factor: 2.188

9.  Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.

Authors:  Jonah B Sacha; Juan P Giraldo-Vela; Matthew B Buechler; Mauricio A Martins; Nicholas J Maness; Chungwon Chung; Lyle T Wallace; Enrique J León; Thomas C Friedrich; Nancy A Wilson; Atsunobu Hiraoka; David I Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

10.  Inflammation and TCR signal strength determine the breadth of the T cell response in a bim-dependent manner.

Authors:  Dietmar Zehn; Sarah Roepke; Kristin Weakly; Michael J Bevan; Martin Prlic
Journal:  J Immunol       Date:  2013-11-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.